Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 210-762-8 | CAS number: 622-97-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: No test guideline quoted. Limited study details. Non-GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 977
- Report date:
- 1977
Materials and methods
- Principles of method if other than guideline:
- Four fixed doses administered concurrently, one to each of four groups on a volume per unit of body weight basis (mL/kg bw).
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- 4-methylstyrene
- EC Number:
- 210-762-8
- EC Name:
- 4-methylstyrene
- Cas Number:
- 622-97-9
- Molecular formula:
- C9H10
- IUPAC Name:
- 1-ethenyl-4-methylbenzene
- Test material form:
- liquid
- Details on test material:
- - Name as cited in study report: MCTR-243-77
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- - Weight at study initiation: 225.8 g to 261.0 g at randomisation
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- - Concentration in vehicle: Test substance administered undiluted
- High dose: 5.0 mL/kg (test substance administered on a volume per unit of body weight basis) - Doses:
- Group 1: 0.6 mL/kg
Group 2: 1.3 mL/kg
Group 3: 2.5 mL/kg
Group 4: 5.0 mL/kg - No. of animals per sex per dose:
- 10 males
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Daily observations for clinical signs and mortality. Body weight determined on day of dosing and at termination / day of premature death.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: Clinical signs, body weights, and macroscopic necropsy examination performed on animals that died / surviving animals on day 14. - Statistics:
- Calculation of LD50 with 95% confidence limits.
Weil, C.S., Biometrics, Vol.8, No.3, 249-263, Tables for Convenient Calculation of Median - Effective Dose (LD50 or ED50) and Instructions in their Use, 1952.
Results and discussion
Effect levels
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 3.68 mL/kg bw
- Based on:
- test mat.
- 95% CL:
- > 2.07 - < 6.52
- Remarks on result:
- other:
- Remarks:
- Based on a relative density of 0.917, this is equivalent to and LD50 of 3375 mg/kg bw
- Mortality:
- Group 1: 1/10 (day of dosing, day 0; attributed to mis-dosing)
Group 2: 0/10
Group 3: 3/10 (2 on day 1 of observation; 1 on day 14)
Group 4: 7/10 (7 on day 1 of observation) - Clinical signs:
- other: Group 1: No signs of toxicity Group 2: No signs of toxicity Group 3: On the day of dosing (day 0), 10/10 animals showed an increase in respiration, slight trembling and slight listlessness; these clinical signs generally persisted until day 2/3 of observa
- Gross pathology:
- Principal macroscopic findings noted for animals in groups 3 and 4 which died included haemorrhagic lungs and small intestsine, clear colourless fluid in the urinary bladder and red oral/nasal/ocular discharge. No significant macroscopic findings noted for animals in Groups 1 and 2.
Applicant's summary and conclusion
- Conclusions:
- Under the study conditions, the calculated oral LD50 was 3.68 mL/kg/bw, with 95% confidence limits of 2.07 to 6.52 mL/kg/bw. Based on a relative density of 0.917, this is equivalent to and LD50 of 3375 mg/kg bw.
- Executive summary:
A study was conducted to determine the toxicity of the test substance in Sprague-Dawley rats. Four groups of 10 male rats were given a single dose of 0.6, 1.3, 2.5 or 5.0 mL/kg bw. The animals were observed for 14 d and mortality and clinical signs were recorded daily. Body weights were determined on Day 0 (day of dosing) and on Day 14. Macroscopic findings were recorded at necropsy of all animals that died or were killed on Day 14. On the day of dosing, all rats at 2.5 mL/kg and 7/10 rats at 5.0 mL/kg had an increase in respiration rate, slight trembling throughout the body and were slightly listless while the other 3 rats were also lying on their side very listlessly. On Days 1 and 2, the rats that survived in the two highest groups were slightly listless and had a slight increase in respiration, with the exception of one rat at the highest dose which was still very listless on Days 1 and 2, and slightly listless on Day 3. All surviving rats were normal thereafter until Day 14 when one rat at 2.5 mL/kg died. Gross necropsy revealed and enlarged lobe of the lung which contained a reddish-yellow, foamy fluid. All other rats were normal on Day 14. Under the study conditions, the calculated oral LD50 was 3.68 mL/kg bw, with 95% confidence limits of 2.07 to 6.52 mL/kg bw. Based on a relative density of 0.917, this is equivalent to an LD50 of 3375 mg/kg bw (Adamik, 1977).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.